Photocure ASA: Invitation to presentation of 4th quarter and preliminary full year 2025 financial results
Oslo, Norway, 11 February 2026: Photocure ASA (Photocure, PHO: OSE) will announce the fourth quarter and preliminary full year 2025 financial results on Wednesday 18 February 2026 at 08:00 CET and will present a live webcast at 14:00 CET the same day.
The quarterly report and presentation will be published at 07:00 CET and will be publicly available at www.photocure.com.
The investor presentation will be streamed live and hosted by Dan Schneider, CEO and Erik Dahl, CFO. The presentation will be held in English and questions can be submitted throughout the event. The presentation is scheduled to conclude at 14:45 CET.
The streaming event is available through https://qcnl.tv/p/0MElVGJID9j2vJqcZ9_SbA
For further information, please contact:
Photocure Erik Dahl CFO Tel: +47 45055000 Email: ed@photocure.com
Priyam Shah Vice President of Investor Relations Tel: +17176815072 Email: priyam.shah@photocure.com
Media enquiries: Geir Bjørlo Corporate Communications (Norway) Tel: +47 91540000 Email: geir.bjorlo@corpcom.no
About Photocure Photocure: The Bladder Cancer Company delivers transformative solutions to improve the lives of bladder cancer patients. Our unique technology, making cancer cells glow bright pink, has led to better health outcomes for patients worldwide. Photocure is headquartered in Oslo, Norway and listed on the Oslo Stock Exchange (OSE: PHO). For more information, please visit us at www.photocure.com and www.cysview.com.
This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.